Gastric bypass might not have long-term benefits in diabetes

11/28/2012 | New York Times (tiered subscription model), The

Thirty-five percent of type 2 diabetes patients who initially experienced disease remission following gastric bypass surgery redeveloped diabetes within five years, while many patients never attained remission after the procedure, a study in Obesity Surgery found. Surgery appeared to be most effective for type 2 diabetes patients without advanced disease, researchers said.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA